Programme

Presentation synopsis:

The burden of histoplasmosis and HIV: Connecting the dots

Progressive Disseminated Histoplasmosis has been the first opportunistic infection and cause of death of HIV-infected patients in French Guiana for the past 3 decades. Elsewhere in Latin America, there are few publications on the subject and apart from a few centers. National and international health organisations have not tackled the problem, clinicians are often unaware of the disease and essential drugs are missing in some affected countries. So far, the burden of the disease of histoplasmosis in HIV-infected persons is unknown but it is probably very large. The present talk will present, country by country, estimates of the burden and efforts to raise awareness in Latin America.

Speaker biography:

Mathieu Nacher is a physician-scientist with formal training in research, public health, and tropical medicine (malaria, leishmaniasis, dengue, zika, HIV, histoplasmosis). He is a professor of Public Health at the University of French Guiana and the director of the Clinical Investigation Center INSERM 1424. He has been the AIDS programme Chair for French Guiana since 2004 and has worked on all aspects of HIV, notably opportunistic infections. During this time, Mathieu Nacher has developed a cooperation network in Latin America on several topics among which histoplasmosis, a neglected pathogen in the region because of the lack of simple diagnostic tool.

He has thus worked on the epidemiology of histoplasmosis among HIV-infected patients and has advocated through scientific papers and international conferences that it is a major neglected killer of HIV-infected persons in Latin America. He has active collaborations in Brazil, Suriname, Colombia, Guatemala, Guyana and the USA on the topic of HIV and histoplasmosis. The overarching goal of these collaborations is to reduce the burden of histoplasmosis.

 

Progressive Disseminated Histoplasmosis has been the first opportunistic infection and cause of death of HIV-infected patients in French Guiana for the past 3 decades. Elsewhere in Latin America, there are few publications on the subject and apart from a few centers. National and international health organisations have not tackled the problem, clinicians are often unaware of the disease and essential drugs are missing in some affected countries. So far, the burden of the disease of histoplasmosis in HIV-infected persons is unknown but it is probably very large. The present talk will present, country by country, estimates of the burden and efforts to raise awareness in Latin America.


Registration

Registration is open

Second Announcement

Take a look

Call for abstracts

Submissions are closed